Hypertrophic cardiomyopathy: A review of etiology and treatment

Journal of Cardiovascular Nursing

Volumn 22, Issue 1, 2007, Pages 65-75

  Jurynec, Jennifer ^a,b  

^a LDS HOSPITAL   (United States)

^b NONE   (United States)

Author keywords

Advanced practice nurse; Cardiomyopathy; Hypertrophic cardiomyopathy; Sudden cardiac death

Indexed keywords

DEFIBRILLATOR; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; INCIDENCE; INHERITANCE; MASS SCREENING; PATHOPHYSIOLOGY; PREVALENCE; REVIEW;

CARDIOMYOPATHY, HYPERTROPHIC; DEFIBRILLATORS, IMPLANTABLE; HUMANS; INCIDENCE; INHERITANCE PATTERNS; MASS SCREENING; PREVALENCE;

EID: 33846310404     PISSN: 08894655     EISSN: 15505049     Source Type: Journal    
DOI: 10.1097/00005082-200701000-00010     Document Type: Review

References (25)

1. Hess OM. Risk stratification in hypertrophic cardiomyopathy: fact or fiction? J Am Coll Cardiol. 2003;42(5):880-881.
2. Spirito P, Seidman CE, McKenna WJ, Maron BJ. The management of hypertrophic cardiomyopathy. N Engl J Med. 1997;336(11):775-785.
3. Corrado D, Basso C, Schiavon M, Thiene G. Screening for hypertrophic cardiomyopathy in young athletes. N Engl J Med. 1998;339(6):364-369.
4. Nishimura RA, Holmes DR Jr. Clinical practice. Hypertrophic obstructive cardiomyopathy. N Engl J Med. 2004;350(13):1320-1327.
5. Kasper LD, Braunwald E, Fauci AS, Hauser SL, Longo DL, Jameson JL. Harrison's Principles of Internal Medicine. 16th ed. New York, NY: McGraw-Hill; 2005.
6. Roberts R, Sigwart U. New concepts in hypertrophic cardiomyopathies, part II. Circulation. 2001;104(18):2249-2252.
7. Maron BJ, McKenna WJ, Danielson GK, et al. American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol. 2003;42(9):1687-1713.
8. Cannon 3rd RO. Assessing risk in hypertrophic cardiomyopathy. N Engl J Med. 2003;349(11):1016-1018.
9. Roberts R, Sigwart U. New concepts in hypertrophic cardiomyopathies, part I. Circulation. 2001;104(17):2113-2116.
10. Elliott P, McKenna WJ. Hypertrophic cardiomyopathy. Lancet. 2004;363(9424):1881-1891.
11. Olivotto I, Maron MS, Adabag AS, et al. Gender-related differences in the clinical presentation and outcome of hypertrophic cardiomyopathy. J Am Coll Cardiol. 2005;46(3):480-487.
12. Maron BJ, Olivotto I, Spirito P, et al. Epidemiology of hypertrophic cardiomyopathy-related death: revisited in a large non-referral-based patient population. Circulation. 2000;102(8):858-864.
13. Maron BJ. Hypertrophic cardiomyopathy: a systematic review. JAMA. 2002;287(10):1308-1320.
14. MacRae CA, Ellinor PT. Genetic screening and risk assessment in hypertrophic cardiomyopathy. J Am Coll Cardiol. 2004;44(12):2326-2328.
15. Nugent AW, Daubeney PE, Chondros P, et al. Clinical features and outcomes of childhood hypertrophic cardiomyopathy: results from a national population-based study. Circulation. 2005;112(9):1332-1338.
16. Eckart RE, Scoville SL, Campbell CL, et al. Sudden death in young adults: a 25-year review of autopsies in military recruits. Ann Intern Med. 2004;141(11):829-834.
17. Maron BJ, Carney KP, Lever HM, et al. Relationship of race to sudden cardiac death in competitive athletes with hypertrophic cardiomyopathy. J Am Coll Cardiol. 2003;41(6):974-980.
18. Biagini E, Coccolo F, Ferlito M, et al. Dilated-hypokinetic evolution of hypertrophic cardiomyopathy: prevalence, incidence, risk factors, and prognostic implications in pediatric and adult patients. J Am Coll Cardiol. 2005;46(8):1543-1550.
19. Sorajja P, Ommen SR, Nishimura RA, Gersh BJ, Berger PB, Tajik AJ. Adverse prognosis of patients with hypertrophic cardiomyopathy who have epicardial coronary artery disease. Circulation. 2003;108(19):2342-2348.
20. Autore C, Bernabo P, Barilla CS, Bruzzi P, Spirito P. The prognostic importance of left ventricular outflow obstruction in hypertrophic cardiomyopathy varies in relation to the severity of symptoms. J Am Coll Cardiol. 2005;45(7):1076-1080.
21. Kumar V, Abbas A, Fausto N. Robbins and Cotran, Pathologic Basis of Disease. 7th ed. Philadelphia, Pa: Elsevier Saunders; 2005.
22. Maron BJ. Sudden death in young athletes. N Engl J Med. 2003;349(11):1064-1075.
23. Elliott PM, Poloniecki J, Dickie S, et al. Sudden death in hypertrophic cardiomyopathy: identification of high risk patients. J Am Coll Cardiol. 2000;36(7):2212-2218.
24. Evangelista LS, Chen J. Hemodynamic benefits of treatment modalities for hypertrophic cardiomyopathy: a case study. J Cardiovasc Nurs. 2001;15(2):33-40.
25. Ommen R, Maron BJ, Olivotto I, et al. Long-term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol. 2005;46(3):470-476.